Hepatocellular Carcinoma

Lipiodol Earns FDA Approval for Tumor Imaging in HCC

Lipiodol Earns FDA Approval for Tumor Imaging in HCC

By

The FDA has approved Guerbet's Lipiodol (ethiozed oil) injection for imaging of hepatocellular carcinoma tumors

Drinking More Coffee May Lower Liver Cancer Risk

Drinking More Coffee May Lower Liver Cancer Risk

Increased coffee consumption may reduce hepatocellular carcinoma risk across ethnicities, according to a study presented at the AACR Annual Meeting.

Novel Kinase Inhibitor Shows Efficacy in Patients with Advanced HCC Tumors Overexpressing AFP

Novel Kinase Inhibitor Shows Efficacy in Patients with Advanced HCC Tumors Overexpressing AFP

By

LY2157299 monohydrate showed promising efficacy results in patients with advanced HCC tumors overexpressing AFP.

Everolimus Failed to Improve Survival in Advanced HCC

Everolimus Failed to Improve Survival in Advanced HCC

By

Data indicate that everolimus did not improve overall survival in patients with advanced HCC following sorafenib failure.

Gastrointestinal Toxicity of Sorafenib

Gastrointestinal Toxicity of Sorafenib

By

Sorafenib can be an effective treatment for a variety of cancers, but its use can come with significant GI side effects.

Anti-CLTA4 Immunotherapy Achieves Antitumor Effects in Small Study of Hepatitis C-Related Hepatocellular Carcinoma

Anti-CLTA4 Immunotherapy Achieves Antitumor Effects in Small Study of Hepatitis C-Related Hepatocellular Carcinoma

By

Immunotherapy targeting the CLTA4 protein in HCV-related HCC demonstrated modest extended survival in a disease that has a high mortality rate.

Targeting Vascular Endothelial Growth Factor in Treatment of Hepatocellular Carcinoma

Targeting Vascular Endothelial Growth Factor in Treatment of Hepatocellular Carcinoma

By

Despite HCC having a poor prognosis and high mortality, systemic antiangiogenesis therapies offer some hope to patients.

Creating a Multidisciplinary Hepatocellular Carcinoma Clinic Improves Survival

By

Forming a multidisciplinary clinic for patients with HCC resulted in improved survival, likely due to more streamlined care and earlier diagnosis, found research presented at SSO 2013.

Survival After Radiofrequency Ablation Might be 'Comparable' to Resection for Liver Cancer

By

Radiofrequency ablation might offer comparable survival rates when compared with liver surgery for patients with hepatocellular carcinoma.

Aspirin Use Associated with Lower Liver Cancer Risk and Chronic Liver Disease Mortality Rates

By

Aspirin use, but not the use of other nonsteroidal anti-inflammatory drugs (NSAIDs), is associated with a reduced risk of developing hepatocellular carcinoma.

RSNA: DEB TACE Viable Treatment Option for Advanced Unresectable HCC

By

Patients with advanced unresectable hepatocellular carcinoma have a higher median overall survival when treated with drug eluting bead transarterial chemoembolization.

DEBs and the Treatment of Unresectable HCC

DEBs and the Treatment of Unresectable HCC

By

Drug-eluting beads are a new type of drug delivery system that may be able to decrease side effects and localize chemotherapy treatment in HCC patients.

Clinical Trial for Novel Liver Cancer Drug Begins

By

The first patient has been treated in a phase 2 clinical trial of intravenous delivery JX-594 in patients with advanced hepatocellular carcinoma.

First-Line Brivanib Fails Against Sorafenib on OS End Point in HCC

By

In a randomized phase 3 trial, first-line brivanib did not meet its primary overall survival end point in patients with hapatocellular carcinoma.

Patients with Alcoholic Cirrhosis at Low Risk for HCC; Surveillance Not Warranted

By

A cohort study of Danish patients with alcoholic cirrhosis suggests that because they are at low risk for hepatocellular carcinoma (HCC), "surveillance would be expected to have a minimal effect on mortality and is unlikely to be cost effective,"

Family History of Liver Cancer, HBV/HCV Infection Increase Risk of HCC

By

The investigators sought to understand the relationships between familial clustering of hepatocellular carcinoma (HCC), family history of liver cancer and the incidence of hepatitis.

Childhood Obesity Increases Risk of Adult HCC

By

Danish researchers have established a link between childhood obesity and hepatocellular carcinoma (HCC) in adults.

SIRT-Sorafenib Combination Shows Efficacy in Patients with HCC

Loco-regional therapy with selective internal radiation therapy (SIRT) and sorafenib demonstrated good efficacy in patients with advanced hepatocellular carcinoma (HCC), especially those in Barcelona Clinic Liver Criteria (BCLC) stage B.

Antisense Drug Makes Sense as Potential Broad-Acting Cancer Therapy

The search for a drug that can treat many different forms of cancer may be over. This comes with news that Isis Pharmaceuticals has initiated a Phase 1 study targeting the expression in tumors of signal transducer and activator of transcription 3 (STAT3), a gene that is ubiquitous and overexpressed in many tumor types.

TACE + Sorafenib Delays HCC Progression in Patients with Chronic HCV Infection

Transarterial chemoembolization (TACE) with sequential sorafenib delayed time to progression (TTP) of intermediate-stage hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection, a prospective randomized study concluded in The Oncologist online February 14.

Liver Cancer

This patient information fact sheet provides information on the basics relating to the liver and the causes of and treatments for liver cancer.

Sign Up for Free e-newsletters

Enter Our April Contest

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs